The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment
Abstract Background Patient engagement (PE) in clinical trials has gained importance yet remains uncommon, particularly in patients with mild cognitive impairment (MCI), a critical precursor to Alzheimer’s disease (AD). Cannabidiol (CBD) shows potential in slowing MCI progression due to its neuropro...
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
BMC
2025-01-01
|
| シリーズ: | BMC Complementary Medicine and Therapies |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s12906-025-04753-w |